Clinical trialNCT07228104RecruitingPhase 3Interventional

Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis

SponsorJohns Hopkins UniversityEnrollment226Idiopathic Subglottic Stenosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will examine the ability of steroid injections into the site of stenosis following surgical dilation to delay the need for repeated surgical dilations.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alexander Hillel, MD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California - San Diego
San Diego, California, United States
Daniel Cates, MD
Not, yet, recruiting
University of California - San Francisco
San Francisco, California, United States
Clark Rosen, MD
Not, yet, recruiting
University of Colorado
Aurora, Colorado, United States
Matthew Clary, MD
Not, yet, recruiting
University of South Florida
Tampa, Florida, United States
Yael Bensoussan, MD
Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Matthew Hoffman, MD, PhD
Not, yet, recruiting
Johns Hopkins Hospital
Baltimore, Maryland, United States
Alexander Hillel, MDKevin Motz, MD
Recruiting
University of Rochester Medical Center
Rochester, New York, United States
G. Todd Schneider, MD, MS
Not, yet, recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Alexander Gelbard, MD
Recruiting
University of Utah
Salt Lake City, Utah, United States
Breanne Schiffer, MD, MPH
Not, yet, recruiting
University of Wisconsin - Madison
Madison, Wisconsin, United States
David Francis, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboTriamcinolone 0.1%

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 May 2026
Primary completion: 1 Jan 2031
Completion: 31 Jan 2032
Last update posted: 21 Aug 2026
Registered enrollment: 226
Registry id: NCT07228104

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.